DCP1A encodes a critical cofactor protein essential for mRNA decapping, a key step in post-transcriptional gene regulation. DCP1A functions as a cofactor for the catalytic subunit DCP2, enhancing its mRNA-binding affinity and facilitating the removal of the 5'-methylguanosine cap structure from mRNA molecules 1. The protein is essential for decapping complex assembly and interactions between the decapping machinery and mRNA cap-binding proteins 2. DCP1A localizes to processing bodies (P-bodies), cytoplasmic ribonucleoprotein granules involved in mRNA degradation, and can influence stress granule formation and composition 3. Functionally, DCP1A is crucial for embryonic development, as knockout mice exhibit embryonic lethality around day 10.5 with growth retardation and cardiac defects 4. In cancer contexts, DCP1A shows elevated expression and contributes to malignancy through multiple mechanisms. High DCP1A expression correlates with poor prognosis in gastric cancer and promotes chemotherapy resistance through AKT and STAT3 pathway activation 5. In colorectal cancer, DCP1A is regulated by the long non-coding RNA MALAT1 and contributes to tumor progression by modulating miR203 levels 6. The protein also enhances miRNA-mediated gene regulation when overexpressed 7.